The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare outcomes in patients undergoing lung transplantation,
using 2 different induction therapies. Primary outcome is survival and secondary outcomes
include freedom from infection and freedom from rejection.